Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Sotlar

Showing results (21-30 of 197) with videos related to

Pageof 20
Sort By:
Cancers|May 25, 2024
Genome-Wide Methylation Analysis in Two Wild-Type Non-Small Cell Lung Cancer Subgroups with Negative and High PD-L1 ExpressionGeorg Hutarew, Beate Alinger-Scharinger, Karl Sotlar, et al.
Immunology and Allergy Clinics of North America|September 27, 2023
World Health Organization Classification and Diagnosis of Mastocytosis: Update 2023 and Future PerspectivesPeter Valent, Karl Sotlar, Hans-Peter Horny, et al.
Virchows Archiv : an International Journal of Pathology|January 22, 2003
Parvovirus B19: a pathogen responsible for more than hematologic disordersBurkhard D Bültmann, Karin Klingel, Karl Sotlar, et al.
Patient Safety in Surgery|July 9, 2014
Necrotizing fasciitis in a young patient with acute myeloid leukemia - a diagnostic challengeMareen Brumann, Viktoria Bogner, Andreas Völkl, et al.
Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists|August 26, 2011
Systemic mastocytosis (SM) and associated malignant bone marrow histiocytosis - a hitherto undescribed form of SM-AHNMDZbigniew Rudzki, Karl Sotlar, Andrzej Kudela, et al.
The Journal of Molecular Diagnostics : JMD|January 1, 2008
Systemic mastocytosis associated with chronic idiopathic myelofibrosis: a distinct subtype of systemic mastocytosis associated with a [corrected] clonal hematological non-mast [corrected] cell lineage disorder carrying the activating point mutations KITD816V and JAK2V617FKarl Sotlar, Anja Bache, Florian Stellmacher, et al.
Annals of Hematology|June 2, 2005
Cladribine therapy in a patient with an aleukemic subvariant of mast cell leukemiaOlaf Penack, Karl Sotlar, Frank Noack, et al.
Leukemia & Lymphoma|October 30, 2004
Aleukemic mast cell leukemia with abnormal immunophenotype and c-kit mutation D816VFrank Noack, Karl Sotlar, Martin Notter, et al.
Cancer Genetics and Cytogenetics|February 22, 2005
Standard mono- and dinucleotide repeats do not appear to be sensitive markers of microsatellite instability in the Ewing family of tumorsMartin Ebinger, Thomas Bock, Reinhard Kandolf, et al.
Breast Care (Basel, Switzerland)|February 22, 2024
Use of the Gene Expression Test Prosigna<sup>®</sup> in Premenopausal Patients with HR+, HER2- Early Breast Cancer: Correlation of the Results with the Proliferation Marker Ki-67Cordula Ziegler, Karl Sotlar, Daniel Maria Hofmann, et al.
Pageof 20

Showing results (21-30 of 197) with videos related to

Sort By:
Pageof 20
Cancers|May 25, 2024
Genome-Wide Methylation Analysis in Two Wild-Type Non-Small Cell Lung Cancer Subgroups with Negative and High PD-L1 ExpressionGeorg Hutarew, Beate Alinger-Scharinger, Karl Sotlar, et al.
Immunology and Allergy Clinics of North America|September 27, 2023
World Health Organization Classification and Diagnosis of Mastocytosis: Update 2023 and Future PerspectivesPeter Valent, Karl Sotlar, Hans-Peter Horny, et al.
Virchows Archiv : an International Journal of Pathology|January 22, 2003
Parvovirus B19: a pathogen responsible for more than hematologic disordersBurkhard D Bültmann, Karin Klingel, Karl Sotlar, et al.
Patient Safety in Surgery|July 9, 2014
Necrotizing fasciitis in a young patient with acute myeloid leukemia - a diagnostic challengeMareen Brumann, Viktoria Bogner, Andreas Völkl, et al.
Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists|August 26, 2011
Systemic mastocytosis (SM) and associated malignant bone marrow histiocytosis - a hitherto undescribed form of SM-AHNMDZbigniew Rudzki, Karl Sotlar, Andrzej Kudela, et al.
The Journal of Molecular Diagnostics : JMD|January 1, 2008
Systemic mastocytosis associated with chronic idiopathic myelofibrosis: a distinct subtype of systemic mastocytosis associated with a [corrected] clonal hematological non-mast [corrected] cell lineage disorder carrying the activating point mutations KITD816V and JAK2V617FKarl Sotlar, Anja Bache, Florian Stellmacher, et al.
Annals of Hematology|June 2, 2005
Cladribine therapy in a patient with an aleukemic subvariant of mast cell leukemiaOlaf Penack, Karl Sotlar, Frank Noack, et al.
Leukemia & Lymphoma|October 30, 2004
Aleukemic mast cell leukemia with abnormal immunophenotype and c-kit mutation D816VFrank Noack, Karl Sotlar, Martin Notter, et al.
Cancer Genetics and Cytogenetics|February 22, 2005
Standard mono- and dinucleotide repeats do not appear to be sensitive markers of microsatellite instability in the Ewing family of tumorsMartin Ebinger, Thomas Bock, Reinhard Kandolf, et al.
Breast Care (Basel, Switzerland)|February 22, 2024
Use of the Gene Expression Test Prosigna<sup>®</sup> in Premenopausal Patients with HR+, HER2- Early Breast Cancer: Correlation of the Results with the Proliferation Marker Ki-67Cordula Ziegler, Karl Sotlar, Daniel Maria Hofmann, et al.
Pageof 20